We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

66 hedge funds and large institutions have $56.3M invested in Cardiff Oncology in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 7

69% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 13

66% more call options, than puts

Call options by funds: $1.91M | Put options by funds: $1.15M

10% more funds holding

Funds holding: 60 → 66 (+6)

5% less capital invested

Capital invested by funds: $59.2M → $56.3M (-$2.99M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
66
Holders Change
+6
Holders Change %
+10%
% of All Funds
1.73%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
22
Reduced
13
Closed
7
Calls
$1.91M
Puts
$1.15M
Net Calls
+$761K
Net Calls Change
-$41K

Top Buyers

1
First Eagle Investment Management
First Eagle Investment Management
New York
+$2.05M
2
BIT
BlackRock Institutional Trust
California
+$474K
3
California Public Employees Retirement System
California Public Employees Retirement System
California
+$420K
4
DADC
D.A. Davidson & Co
Montana
+$373K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$371K

Top Sellers

1
TCM
Tekla Capital Management
Massachusetts
-$3.13M
2
TI
Turner Investments
Pennsylvania
-$990K
3
HighTower Advisors
HighTower Advisors
Illinois
-$607K
4
Millennium Management
Millennium Management
New York
-$284K
5
SM
Sabby Management
Florida
-$217K
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teachers Advisors
New York
$259K +$29K +74 +13%
EP
27
Elkhorn Partners
Nebraska
$251K +$19.2K +49 +8%
Ameriprise
28
Ameriprise
Minnesota
$243K +$244K +623 New
MSTVIM
29
Messner & Smith Theme Value Investment Management
California
$197K -$10.6K -27 -5%
Charles Schwab
30
Charles Schwab
California
$191K – – –
QSS
31
Quantitative Systematic Strategies
Florida
$149K +$146K +373 New
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$147K +$23.1K +59 +19%
HCM
33
Highlander Capital Management
New Jersey
$144K – – –
HighTower Advisors
34
HighTower Advisors
Illinois
$135K -$607K -1,549 -82%
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
$120K – – –
CS
36
Credit Suisse
Switzerland
$119K -$130K -331 -52%
RHBC
37
R.H. Bluestein & Co
Michigan
$108K -$24.3K -62 -18%
NFA
38
Nationwide Fund Advisors
Ohio
$106K +$6.27K +16 +6%
Wells Fargo
39
Wells Fargo
California
$95K +$75.2K +192 +362%
OAM
40
Oxford Asset Management
United Kingdom
$84K +$83.4K +213 New
Citadel Advisors
41
Citadel Advisors
Florida
$81K +$81.8K +209 New
Deutsche Bank
42
Deutsche Bank
Germany
$80K -$138K -353 -63%
VOYA Investment Management
43
VOYA Investment Management
Georgia
$71K – – –
BA
44
BlackRock Advisors
Delaware
$70K -$35.2K -90 -33%
AL
45
Airain Ltd
Guernsey
$70K +$70.1K +179 New
Bank of Montreal
46
Bank of Montreal
Ontario, Canada
$57K -$25.8K -66 -31%
Creative Planning
47
Creative Planning
Kansas
$42K – – –
WP
48
WealthPLAN Partners
Nebraska
$41.3K +$41.5K +106 New
UBS Group
49
UBS Group
Switzerland
$41K +$11.4K +29 +38%
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
$40.7K +$3.52K +9 +9%
1
2
3

CRDF Hedge Fund Activity: Q4 2015 in Review

66 of the 3,811 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q4 2015, worth a combined $56.3M — down 5% from $59.2M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new CRDF positions and 7 closed out — a net gain of 6 holders — while 22 added to existing stakes and 13 trimmed.

The largest buyer was First Eagle Investment Management, opening a new position worth an estimated $2.05M. The largest seller was Tekla Capital Management, exiting entirely with an estimated $3.13M sold.

  • 66 institutional investors held Cardiff Oncology (CRDF) as of Q4 2015, up from 60 in Q3 2015.
  • Funds reported $56.3M of Cardiff Oncology stock for Q4 2015, down 5% quarter-over-quarter.
  • 13 funds opened new Cardiff Oncology positions in Q4 2015 and 7 closed out, a net change of +6 holders.
  • The largest Cardiff Oncology buyer in Q4 2015 was First Eagle Investment Management, an estimated $2.05M added.
  • The largest Cardiff Oncology seller in Q4 2015 was Tekla Capital Management, an estimated $3.13M sold.

Based on aggregated 13F filings for Q4 2015.